CARE CHL Hospitals | Indore, LIG Square - Endocrinology department
Research site
Site insights
Top conditions
Top treatments
LY3298176
Tirzepatide
LY3437943
Saroglitazar
Retatrutide
GL0034
Parent organization
This site is a part of CARE CHL Hospitals, Indore
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Contact this site
Madhumati Pahuja
Verified by this site
Active trials
3 of 7 total trials
The purpose of this study is to is to evaluate the efficacy and safety of retatrutide in participants with type 2 diabetes in participants who have o...
Active, not recruiting
Overweight
Obesity
Drug: Placebo
Drug: Retatrutide
A Phase 4, non-randomized, multicentre, open-label, single-arm study to evaluate the safety and efficacy of Saroglitazar 4 mg in patients with non-al...
Enrolling
Dyslipidemias
Obesity
Drug: Saroglitazar
This is a phase II, randomized, double-blind, placebo-controlled study to evaluate the efficacy and tolerability of GL0034 among type II diabetes mel...
Enrolling
Type II Diabetes Mellitus
Drug: GL0034 Dose Level 4
Drug: GL0034 Dose Level 3
Trial sponsors
X
Z
T
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems